Skip to main content
. 2022 Feb 10;10(2):269. doi: 10.3390/vaccines10020269

Figure 3.

Figure 3

Figure 3

The thermal stability of the vaccine. A7 was tested at 2–8 °C (a); the A7 and commercial vaccines at 37 °C (b) and 45 °C (c) were tested in three lots (001, 002, and 003). The freeze-dried DHV vaccine without added stabilizer was assessed as the negative control group.